Volume 101, Issue 1 pp. 41-46

Myasthenia gravis: a retrospective study comparing thymectomy to conservative treatment

L. C. Werneck

L. C. Werneck

From the Neuromuscular Service and Neurology Division of the Internal Medicine Department, Hospital de Clinicas, Universidade Federal do Parana´ , Curitiba, Brazil

Search for more papers by this author
F. M. B. Cunha

F. M. B. Cunha

From the Neuromuscular Service and Neurology Division of the Internal Medicine Department, Hospital de Clinicas, Universidade Federal do Parana´ , Curitiba, Brazil

Search for more papers by this author
R. H. Scola

R. H. Scola

From the Neuromuscular Service and Neurology Division of the Internal Medicine Department, Hospital de Clinicas, Universidade Federal do Parana´ , Curitiba, Brazil

Search for more papers by this author
First published: 29 November 2012
Citations: 21
Dr Lineu Cesar Werneck, Neurology Division, Hospital de Clinicas, Rua Gal. Carneiro 181, 12 andar, 80060-900 Curitiba, Brazil

Abstract

Objectives– To study the effectiveness of thymectomy (TY) in a group of patients with myasthenia gravis compared to a group of patients submitted to conservative treatment (CT) at a similar clinical stage. Methods – Among 153 patients with myasthenia gravis, we paired 28 patients who underwent TY, with 28 cases under CT. The following data were analyzed: gender, age, and age at the beginning of symptoms, illness duration, follow-up time and type of medical treatment. There was no statistical difference between these 2 groups. The mean time for TY was 2.5 (0.2-13) years after the onset of the disease. The cases were evaluated through a functional scale at the beginning and at the end of the study. Results – We found complete remission in 15 cases (TY 6, CT 9), improved (normal life with or without minimal symptoms and with or without medication) 9 cases (TY 8, CT 1), improved with partial control and minimal limitation 32 cases (TY 14, CT 18), and poor control 2 cases (TY 2). No death was found in this group. Conclusion – There was no statistical difference between the conservative treatment and thymectomy groups, regarding remission or improvement. Furthermore TY done in the first year of the disease or latter, did not change the ®naloutcome.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.